In March 2016, two psychologists at the University of Padua published a review article in Frontiers in Human Neuroscience with the deliberately provocative title: "Bread and Other Edible Agents of Mental Disease." It was peer-reviewed, PubMed-indexed, and written, as the authors stated, in deliberately plain English — because they wanted psychiatrists and psychologists to actually read it.
The reception was predictable. Some welcomed it as a necessary challenge to a field that had become over-reliant on pharmacological intervention and under-interested in nutrition. Others dismissed it as scaremongering dressed up in academic language. A prominent science blogger called it "Frontiers' Bread Madness."
Almost nobody engaged seriously with the actual mechanisms — which is a shame, because the mechanisms are where the interesting science is. And a decade on, those mechanisms have substantially more supporting evidence than they did in 2016.
Source Paper
Bread and Other Edible Agents of Mental Disease
Bressan P, Kramer P · Front. Hum. Neurosci. 10:130 · March 2016 · PubMed ID: 27065833
A review article examining how cereal grains affect human behaviour and mental health through gut permeability and opioid-like peptide mechanisms. Written by psychologists at the University of Padua to make an interdisciplinary case to colleagues who typically lack training in gastroenterology, immunology, and nutritional science.
Read the full paper → frontiersin.org
Two independent mechanisms — both pointing in the same direction
The paper's core argument is that bread affects mental health through two distinct pathways. These are not alternative theories — they are additive. Both can operate simultaneously. And crucially, both are relevant to people who do not have coeliac disease and do not consider themselves gluten sensitive.
What makes this more than theoretical is the epidemiological data. The paper cites several convergent lines of evidence that are difficult to explain away.
The evidence that should have changed the conversation
World War II — The Natural Experiment
Wheat shortages correlate with falling schizophrenia rates
During WWII, wheat was scarce across multiple European countries. Hospital admissions for schizophrenia dropped significantly during these periods and rose again when wheat consumption returned to pre-war levels. This pattern was observed independently in multiple countries. It does not prove causation — but it is a striking correlation that has never been adequately explained by alternative hypotheses.
South Pacific — The Introduction Study
Schizophrenia rates rise 300-fold with grain introduction
In South Pacific island populations with traditionally low wheat consumption, schizophrenia prevalence was approximately 1 in 30,000. When Western grain products were introduced, rates rose to approximately 1 in 100 — a 300-fold increase. This is not explained by diagnostic drift or increased reporting. These populations had no prior exposure to wheat exorphins and no established genetic adaptation to grain consumption.
Clinical Trials — Gluten-Free Diet in Schizophrenia
Patients transferred from locked to open wards on grain-free diet
In a controlled clinical setting, patients on a grain-and-milk-free diet were discharged or transferred from locked to open wards significantly sooner than patients on a grain-rich diet. The effect was cancelled when, blind to both patients and staff, the grain-free diet was supplemented with gluten. The mechanism — not the diet in general, but specifically the gluten — was the active variable.
Case Reports — Hallucinations Resolved on Gluten Removal
Daily auditory and visual hallucinations resolved from childhood on GFD
A 2014 case report (Genuis and Lobo) described an adult patient who had experienced highly distressing auditory and visual hallucinations daily from early childhood. Upon removal of gluten from the diet, the hallucinations resolved completely. This was a single case — but the mechanism is consistent with exorphin penetration of the blood-brain barrier in a person with both increased gut permeability and increased BBB permeability.
Autism Research — 80% Symptom Improvement
Gluten and casein-free diet improves symptoms in majority of autistic children studied
Multiple studies have found significant symptom improvement in autistic children on combined gluten-free and casein-free diets — casein from dairy produces its own exorphins (casomorphins) through an identical mechanism. Approximately 80% showed improvement in some studies. Recovery in some cases. The mainstream response has been to dispute the methodology rather than investigate the mechanism.
The addiction dimension — why people crave the food that harms them
One of the most clinically useful insights in the paper — and one that resonates strongly with anyone who has tried to support a client through a gluten elimination — is the opioid addiction model for food sensitivity.
Exorphins bind opioid receptors. Opioids produce tolerance. When you remove an opioid, you get withdrawal. The paper makes the explicit observation that the people who are most hypersensitive to gluten — who are most harmed by it — are precisely the people who crave it most intensely and experience the most severe withdrawal symptoms when they remove it.
"Ironically, the greater the potential benefit of a change in diet, the greater the resistance to it may be. Grain's exorphins can create addiction. It has been estimated that half of the people who are hypersensitive crave the very food that causes them harm and experience withdrawal symptoms when they remove it from their diet."
This is not a moral failing or a lack of willpower. It is a pharmacological response to a food-derived opioid. The patient who cannot sustain a gluten elimination despite wanting to, despite feeling better when they do, is exhibiting classical opioid withdrawal behaviour. Treating this as a compliance problem rather than a biochemical one is — to put it mildly — clinically incomplete.
The zonulin connection — what the GI-MAP actually measures
The gut permeability mechanism described in the Bressan and Kramer paper centres on zonulin — the protein released by intestinal cells in response to gluten that regulates tight junction opening. This is not hypothetical. Alessio Fasano's research group at Harvard has been documenting the zonulin pathway for over two decades, and zonulin is now a measurable clinical marker.
The GI-MAP stool test — which forms part of the Tier 2 and Tier 3 Resilient Gut System programme — includes zonulin as a specific marker of intestinal permeability. An elevated zonulin result is direct evidence that the gut barrier has been compromised. It does not tell you the cause — gluten, stress, dysbiosis, and NSAID use all trigger zonulin release — but combined with symptom history and dietary pattern, it builds the clinical picture.
What the paper didn't have in 2016 — and what is now routinely available — is the ability to measure this in an individual rather than inferring it from population data. If your zonulin is elevated, your gut is permeable. If your gut is permeable and you are eating gluten, exorphins that should stay in the gut are crossing into the bloodstream. If your blood-brain barrier integrity is also compromised — which chronic systemic inflammation tends to produce — those exorphins can reach the brain.
This is not a theory about sensitive people. This is a cascade of measurable events in identifiable individuals.
The Three-System Overlap
The most clinically significant presentations sit at the intersection of three systems: gut permeability (zonulin elevated on GI-MAP), methylation impairment (MTHFR variant, elevated homocysteine, FIGLU on OAT), and neurochemical dysregulation (5-HIAA, HVA on OAT, neurotransmitter metabolites on DUTCH). These are not alternative explanations for the same symptoms. They are additive mechanisms that compound each other. Gluten-driven gut permeability increases systemic inflammation that impairs methylation. Impaired methylation reduces the neurotransmitters needed to regulate mood and stress. A person at all three intersections simultaneously is not going to respond to an SSRI alone — and the failure is not theirs.
A note on the criticism — and why it matters
The Bressan and Kramer paper was criticised, and some of the criticism was legitimate. A 2016 rebuttal piece noted that several of the cited studies were small, that the mechanistic extrapolation from rat data to human clinical outcomes required more caution, and that writing a paper designed to be accessible to non-specialists risked oversimplifying complex and contested science.
These are fair points. The paper is a review, not a clinical trial. It aggregates evidence from multiple disciplines and draws conclusions that the authors acknowledge are hypothesis-generating rather than definitive. The headline claim — that removing bread could cure schizophrenia — is stronger than the underlying evidence base supports as a universal statement.
What the criticism did not do — and what remains the more significant failure — is engage with the core mechanism. Zonulin-mediated gut permeability in response to gluten is not disputed. Exorphin production from gluten digestion is not disputed. Opioid receptor binding by food-derived peptides is not disputed. The question is not whether these mechanisms exist. The question is how significant they are in any given individual — and that is precisely the kind of individual assessment that functional testing makes possible.
"The question is not whether these mechanisms exist. The question is how significant they are in this individual — and that is the kind of question that functional testing was designed to answer."
Bringing it back to the flour
This is the third post in a series that started with the UK government's decision to add synthetic folic acid to all non-wholemeal wheat flour from end of 2026. The folic acid story, the MTHFR and mental health story, and this story about gluten, exorphins, and gut permeability are not separate topics. They are facets of the same clinical picture.
We are about to add a poorly converting synthetic nutrient to a food that — through independent mechanisms — increases gut permeability, produces opioid-like peptides, and in MTHFR variant carriers, impairs the methylation cycle that produces neurotransmitters. The combination of mandatory folic acid in wheat flour, consumed daily by a population of whom nearly half carry impaired methylation genetics and many have unrecognised gut permeability, is a public health intervention that has not been evaluated for its psychiatric consequences.
That is not scaremongering. It is a straightforward observation about the absence of a safety evaluation for a specific population subset — one that the mandatory fortification policy has not addressed and that the psychiatric system is not equipped to monitor.
Test. Don't guess. Know your zonulin. Know your MTHFR status. Know your homocysteine. Know your neurotransmitter metabolites. Because the system that is adding folic acid to your flour is not going to check any of those things for you.